Form 4: Cartesian COO Exercises Stock Options
Insider Transaction Report
Cartesian Therapeutics' Chief Operations Officer, Emily English, exercised 7,500 stock options at $3.30 per share, increasing her direct common stock holdings.
Summary
- Emily English, Chief Operations Officer of Cartesian Therapeutics, Inc. (RNAC), exercised 7,500 stock options.
- The transaction occurred on December 30, 2025, at an exercise price of $3.30 per share.
- Following the exercise, Emily English directly beneficially owns 70,226 shares of common stock.
- The exercised options were fully vested and exercisable.
- These options originated from Old Cartesian common stock options, converted into options for the issuer's common stock following a merger on November 13, 2023.
- After the transaction, Emily English directly beneficially owns 19,369 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The exercise of stock options by a Chief Operations Officer is a routine insider transaction. While it increases direct ownership, which can be seen as a minor positive signal of confidence, it does not inherently indicate significant new developments or a strong bullish/bearish stance.
Positives
- An insider, the Chief Operations Officer, increased her direct common stock holdings by exercising options, which can be interpreted as a sign of confidence in the company's future.
- The options were fully vested and exercisable, indicating a planned and routine transaction.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
This Form 4 filing reports a routine insider transaction and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The transaction results in a minor increase in direct insider ownership, which could be viewed as a positive signal of management alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 11/13/2023 | Issuer acquired the Delaware corporation then-known as Cartesian Therapeutics, Inc. ('Old Cartesian'), converting options to purchase Old Cartesian common stock into options to purchase shares of the issuer's common stock. |
| 12/30/2025 | Date of transaction where 7,500 stock options were exercised. |
| 01/02/2026 | Date the Form 4 was signed by the Attorney-in-Fact for Emily English. |
| 04/25/2031 | Expiration date of the exercised stock options. |
Keywords
Cartesian Therapeutics, RNAC, Stock Option Exercise, Insider Transaction, Form 4, Emily English, COO, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.